The rapid progression of sepsis—a dysregulated immune response mounted by the host in response to an infection—can be life-threatening. (IMAGE)
Caption
Cell-based therapies can potentially restore normal immune function and treat organ failure in sepsis. Medical researchers have embarked on clinical trials and pre-clinical studies to investigate the efficacy and safety of such therapies, signaling a promising new avenue in sepsis treatment.
Credit
Professor Xiangming Fang of Zhejiang University, China
Usage Restrictions
Cannot be reused without permission
License
Original content